There are 2789 resources available
274P - Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Efficacy and safety results of the advanced breast cancer (ABC) patients (pts) cohort of the MOVIE study
Presenter: Thibault De La Motte Rouge
Session: ePoster Display
360P - Metronomic temozolomide therapy in heavily pretreated patients with recurrent glioblastoma: A large mono-institutional retrospective study
Presenter: Vittorina Zagonel
Session: ePoster Display
361P - Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study
Presenter: Alexandre Beige
Session: ePoster Display
439P - Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study
Presenter: John Strickler
Session: ePoster Display
440P - Response to BRAF inhibitors combined with anti-EGFR after previous anti-EGFR exposure for BRAF V600E mutant metastatic colorectal cancer patients
Presenter: Emilie Hafliger
Session: ePoster Display
441P - A study of vemurafenib and cetuximab in combination with FOLFIRI for patients with BRAF V600E-mutated advanced colorectal cancer (NCT03727763): Preliminary results
Presenter: Zhan Wang
Session: ePoster Display
298P - Clinical implication of gene alterations revealed by comprehensive genomic profiling and clonal hematopoiesis in relapsed breast cancer patients
Presenter: Lanxin Zhang
Session: ePoster Display
299P - MicroRNAs-449 regulate doxorubicin response through ACSL4 modulation in TNBC
Presenter: sandra Torres Ruiz
Session: ePoster Display
300P - Mutational patterns across breast cancer subtypes during metastatic disease progression
Presenter: Hao Liao
Session: ePoster Display
301P - Integrins in different subsets of circulating tumor cells in breast cancer
Presenter: Evgeniya Grigoryeva
Session: ePoster Display